We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Vicotex

Download Mobile App




Easy and Cost-Effective Production of Functional siRNA Achieved with Generation Kit

By LabMedica International staff writers
Posted on 26 May 2010
A siRNA generation kit enables easy and cost-effective generation of a large number of small interfering RNAs (siRNAs) from full-length target genes.

siRNAs are 21-23-nucleotide RNA molecules that can cause targeted gene silencing in mammalian cells through a process known as RNA interference. More...
In nature, siRNAs are generated by ribonuclease III cleavage of longer double-stranded RNAs (dsRNAs). When dsRNAs are transfected directly into mammalian cells, they activate the interferon system and provoke nonspecific gene suppression and cytotoxic response. siRNAs have proven to be effective at specifically silencing gene expression without causing any interferon response.

Using an ultra-active form of human recombinant dicer enzyme, a double-stranded RNA-specific endonuclease, it is possible using the kit to cleave more than 95% of dsRNA template into 22 bp [base pair] siRNAs within two hours under optimized reaction conditions. In contrast to individual synthetic siRNAs, the Turbo Dicer kit allows the user to quickly produce multiple siRNA species against the target mitochondrial RNA (mRNA), and thereby achieve effective gene silencing with minimal guesswork. Moreover, due to the minimal concentration of any individual siRNA species generated with the Turbo Dicer enzyme, off-target effects are not a problem.

For maximum convenience, the Turbo Dicer siRNA generation kit, developed by from Amsbio (Abingdon, UK), contains everything that is required for preparing double-stranded RNA from the user's target gene(s), dsRNA cleavage, siRNA cleanup, and transfection. Both the Recombinant Turbo Dicer enzyme and the RNA purification columns are also available separately.

AMS Biotechnology (Amsbio) is a leading international provider of products and custom services for life sciences research. The company's range includes over 23,000 polyclonal and monoclonal antibodies, peptides, recombinant proteins, extracellular matrix, molecular detection reagents, tissue DNA, RNA, protein, and microarray products. Key research areas include apoptosis, cell invasion and migration, cell signaling, DNA damage, electrophoresis, glycobiology, posttranslational modification, and stem cell biology.

Related Links:
Amsbio



Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
Gold Member
Automatic Hematology Analyzer
CF9600
Prefilled Tubes
Prefilled 5.0ml Tubes
Immunofluorescence Analyzer
IFA System
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Researchers developed three mathematical biomarkers from routine PSA blood tests that may help predict early prostate cancer treatment outcomes and personalize adaptive therapy (Image Credit: Adobe Stock)

Mathematical Biomarkers Use Routine Blood Tests to Guide Adaptive Prostate Cancer Therapy

Personalizing systemic therapy for prostate cancer remains challenging because tumors can evolve under treatment pressure, driving resistance and early relapse. Continuous high-dose regimens may initially... Read more

Molecular Diagnostics

view channel
Image: The duet mosaic family comprises duet +modC mosaic and duet 6-base mosaic, two cfDNA-optimized multiomic sequencing workflows for liquid biopsy and translational research. (Photo courtesy of bimodal)

New Liquid Biopsy Workflow Maximizes Tumor Signals from Limited Blood Samples

Liquid biopsy seeks to detect tumor-derived signals from small blood samples, but circulating cell-free DNA is scarce and heterogeneous, limiting sensitivity. Combining complementary signals such as methylation,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.